Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-country, Multi-centre, Observational, Retrospective Study to Reveal the Patient Characteristics, Disease Burden, Treatment Patterns and Patient Journey of Stage III Non-small-cell Lung Cancer Patients

NCT03725475 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT03725475
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03725475 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-country, Multi-centre, Observational, Retrospective Study to Reveal the Patient Characteristics, Disease Burden, Treatment Patterns and Patient Journey of Stage III Non-small-cell Lung Cancer Patients
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
November 26, 2018
Completion date
September 30, 2019
Enrollment
3,111 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

non-small-cell lung cancer (nsclc)